Table 1.
Prevalence of elevated hs-troponina, overall and according to characteristics of US adults aged 18 or older without a history of CVD, NHANES 1999–2004
| Elevated (>99 percentile) hs-troponin T by Rochea | Elevated (>99 percentile) hs-troponin I by Abbotta | Elevated (>99 percentile) hs-troponin I by Siemensa | Elevated (>99 percentile) hs-troponin I by Orthoa | |
|---|---|---|---|---|
| Total, % | 3.11 | 0.60 | 0.93 | 0.75 |
| Gender, % | ||||
| Male | 2.54 | 0.52 | 1.02 | 0.66 |
| Female | 3.62 | 0.67 | 0.85 | 0.82 |
| Age categories, % | ||||
| 18–39 years | 0.33 | 0.36 | 0.41 | 0.32 |
| 40–59 years | 1.74 | 0.38 | 0.70 | 0.48 |
| 60 years or older | 12.6 | 1.64 | 2.64 | 2.32 |
| Race/ethnicity, % | ||||
| NH White | 3.34 | 0.55 | 0.81 | 0.74 |
| NH Black | 4.35 | 1.48 | 1.71 | 1.50 |
| Mexican–American | 1.19 | 0.43 | 0.88 | 0.22 |
| Other/other Hispanic | 1.66 | 0.16 | 1.00 | 0.41 |
| Hypertension, % | ||||
| No | 1.51 | 0.37 | 0.60 | 0.44 |
| Yes | 7.70 | 1.21 | 1.82 | 1.57 |
| Hypercholesterolemia, % | ||||
| No | 2.49 | 0.51 | 0.79 | 0.65 |
| Yes | 5.15 | 0.89 | 1.40 | 1.05 |
| eGFR, mL/min/1.73 m2, % | ||||
| >90 | 1.84 | 0.34 | 0.57 | 0.36 |
| 60–90 | 21.3 | 0.96 | 2.36 | 1.28 |
| <60 | 65.3 | 7.86 | 5.35 | 11.4 |
| Smoking status, % | ||||
| Current | 2.08 | 0.49 | 0.62 | 0.43 |
| Former | 4.75 | 0.77 | 1.38 | 1.37 |
| Never | 2.84 | 0.57 | 0.87 | 0.61 |
| Family history of CVD, % | ||||
| No | 3.32 | 0.64 | 1.02 | 0.79 |
| Yes | 1.83 | 0.36 | 0.36 | 0.50 |
| Diabetes mellitus, % | ||||
| No | 2.73 | 0.55 | 0.88 | 0.74 |
| Yes | 10.1 | 1.55 | 1.97 | 0.91 |
| BMI, kg/m2, % | ||||
| <25 | 3.36 | 0.63 | 0.98 | 0.72 |
| 25–30 | 2.87 | 0.53 | 0.99 | 0.85 |
| >30 | 3.10 | 0.64 | 0.81 | 0.65 |
BMI, body mass index; CVD, cardiovascular disease; eGFR, estimated glomerular filtration ratio using the creatinine cystatin equation; HDL, high-density lipoprotein; NH, non-Hispanic; SBP, systolic blood pressure; URL, upper reference limit.
Values above the manufacturer-designated assay- and sex-specific 99th percentile URL myocardial injury threshold were defined as elevated; troponin T 14(f)/22(m) ng/L; troponin I, Abbott 17(f)/35(m) ng/L; troponin I, Siemens 39.6(f)/58(m) ng/L; troponin I, Ortho 9(f) 12(m) ng/L.